6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Anaplastic Glioma of BrainGlioblastoma MultiformeBrain Cancer
Interventions
DRUG

Capecitabine

Arms 1,3 = 825 mg/m\^2 By Mouth (PO) Every 12 Hours on Day 14-27; Arms 2,3 = 825 mg/m\^2 PO Every 12 Hours on Day 11-24.

DRUG

Celecoxib (Celebrex)

Arms 1,3 = 400 mg PO Every 12 Hours On Day 14-27; Arms 2,3 = 400 mg PO Every 12 Hours On Day 11-24.

DRUG

Temozolomide

Arms 1,3 = 150 mg/m\^2 PO Daily On Day 4-8.

DRUG

Lomustine

Arms 2,3 = 100 mg/m\^2 PO on Day 4.

DRUG

6-Thioguanine

Arms 1,2,3 = 80 mg/m\^2 PO Every 6 Hours on Day 1-3.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00504660 - 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients | Biotech Hunter | Biotech Hunter